Literature DB >> 1396777

Post-antibiotic effect of the new streptogramin RP 59500.

N X Chin1, H C Neu.   

Abstract

The post-antibiotic effect (PAE) of RP 59500, a new streptogramin antibiotic, was determined for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Streptococcus pneumoniae, and Streptococcus pyogenes. A 30 min exposure of Staphylococcus aureus to 5 micrograms/ml of RP 59500 produced a PAE of 1.9-6.9 h, and a 60 min exposure of 2.5 micrograms/ml produced a PAE of 3.2-8 h. A 30 min exposure of 5 micrograms/ml of RP 59500 of coagulase-negative staphylococci produced a PAE of 2.5-7.5 h. PAEs of constitutively erythromycin-resistant staphylococcal isolates were shorter than were the PAEs of highly susceptible isolates. A 30 min exposure to 5 micrograms/ml of RP 59500 produced a PAE of 7.5-9.5 h for Streptococcus pneumoniae and a PAE of greater than 18 h for Streptococcus pyogenes. RP 59500 produced a longer PAE with Staphylococcus aureus than did vancomycin, oxacillin or erythromycin. These results suggest that RP 59500 may be administered less frequently than would be suggested by its half-life.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396777     DOI: 10.1007/bf01961676

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

Review 1.  Methicillin-resistant Staphylococcus aureus. Detection, epidemiology, and control measures.

Authors:  J M Boyce
Journal:  Infect Dis Clin North Am       Date:  1989-12       Impact factor: 5.982

2.  Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

Authors:  H M Blumberg; D Rimland; D J Carroll; P Terry; I K Wachsmuth
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  The Action of Penicillin on Staphylococcus: Further Observations on the Effect of a Short Exposure.

Authors:  R F Parker; S Luse
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

4.  The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  J Bacteriol       Date:  1950-05       Impact factor: 3.490

5.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

7.  Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

Authors:  N X Chin; H C Neu
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

  7 in total
  9 in total

Review 1.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.

Authors:  D Andes; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.

Authors:  R Garcia; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

Review 4.  Quinupristin-dalfopristin.

Authors:  H M Bryson; C M Spencer
Journal:  Drugs       Date:  1996-09       Impact factor: 9.546

5.  Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.

Authors:  J R Aeschlimann; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.

Authors:  J Vouillamoz; J M Entenza; C Féger; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 7.  Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.

Authors:  R G Finch
Journal:  Drugs       Date:  1996       Impact factor: 9.546

8.  Pronounced postantibiotic effect of quinupristin-dalfopristin in static cultures of Staphylococcus aureus: an effect not seen with other antibiotics.

Authors:  E Pfeil; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.